Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 38,316 | 33,623 | 66,772 | 23,705 | 24,232 |
| Operating Income | -38,316 | -33,623 | -66,772 | -23,705 | -24,232 |
| Other Income | 3,338 | 2,224 | 2,385 | 3,072 | 3,668 |
| Pre-tax Income | -34,978 | -31,399 | -64,387 | -20,633 | -20,564 |
| Net Income Continuous | -34,978 | -31,399 | -64,387 | -20,633 | -20,564 |
| Net Income | $-34,978 | $-31,399 | $-64,387 | $-20,633 | $-20,564 |
| EPS Basic Total Ops | -0.83 | -0.90 | -1.90 | -0.60 | -0.61 |
| EPS Basic Continuous Ops | -0.83 | -0.90 | -1.90 | -0.60 | -0.61 |
| EPS Diluted Total Ops | -0.83 | -0.90 | -1.90 | -0.60 | -0.61 |
| EPS Diluted Continuous Ops | -0.83 | -0.90 | -1.90 | -0.60 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -0.90 | -1.90 | -0.60 | -0.61 |
| EBITDA(a) | $-38,316 | $-33,623 | $-66,772 | $-23,705 | $-24,232 |